Localisation of N-acetylaspartate in oligodendrocytes/myelin
暂无分享,去创建一个
[1] H. Tallan,et al. N-Acetyl-L-aspartic acid in brain. , 1956, The Journal of biological chemistry.
[2] F. Fonnum,et al. SUBCELLULAR LOCALIZATION OF N‐ACETYL‐ASPARTYL‐GLUTAMATE, N‐ACETYL‐GLUTAMATE AND GLUTATHIONE IN BRAIN , 1969, Journal of neurochemistry.
[3] K. Daneshbod,et al. Familial spongy degeneration of the brain. , 1970, Archives of neurology.
[4] M. Adachi,et al. Electron microscopic and enzyme histochemical studies of the cerebellum in spongy degeneration (van Bogaert and Bertrans type). , 1972, Acta neuropathologica.
[5] T. Patel,et al. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. , 1979, The Biochemical journal.
[6] J. Storm-Mathisen,et al. Glutamate‐ and GABA‐containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique , 1984, The Journal of comparative neurology.
[7] M. Brownstein,et al. N‐Acetylation of L‐Aspartate in the Nervous System: Differential Distribution of a Specific Enzyme , 1985, Journal of neurochemistry.
[8] R. Kaul,et al. Purification, Characterization, and Localization of Aspartoacylase from Bovine Brain , 1991, Journal of neurochemistry.
[9] N. Herschkowitz,et al. N-acetyl-L-aspartate is a major source of acetyl groups for lipid synthesis during rat brain development. , 1991, Developmental neuroscience.
[10] J. Coyle,et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.
[11] J. Neale,et al. Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.
[12] J. Neale,et al. Enhanced carbodiimide fixation for immunohistochemistry: application to the comparative distributions of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat brain. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] R. Kaul,et al. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease , 1993, Nature genetics.
[14] A Heerschap,et al. Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. , 1995, Clinical chemistry.
[15] G Tedeschi,et al. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging , 1995, Neurology.
[16] J. Coyle,et al. N-Acetylaspartate in neuropsychiatric disorders , 1995, Progress in Neurobiology.
[17] J. Moffett,et al. Differential distribution of N-acetylaspartylglutamate and N-acetylaspartate immunoreactivities in rat forebrain , 1995, Journal of neurocytology.
[18] P. Matthews,et al. Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.
[19] M. Namboodiri,et al. N-acetylaspartate as an acetyl source in the nervous system. , 1995, Brain research. Molecular brain research.
[20] J. Duyn,et al. Quantitative proton MR spectroscopic imaging of the human brain , 1996, Magnetic resonance in medicine.
[21] M. Gotoh,et al. Brain Tissue Acidosis: Effects on the Extracellular Concentration of N‐Acetylaspartate , 1997, Journal of neurochemistry.
[22] J S Wolinsky,et al. Serial proton magnetic resonance spectroscopic imaging, contrast‐enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis , 1998, Annals of neurology.
[23] F. Fonnum,et al. Synaptic Vesicular Localization and Exocytosis ofl-Aspartate in Excitatory Nerve Terminals: A Quantitative Immunogold Analysis in Rat Hippocampus , 1998, The Journal of Neuroscience.
[24] A. Sewell,et al. N-acetylaspartylglutamate in Canavan disease: an adverse effector? , 1999, European Journal of Pediatrics.
[25] R. Matalon,et al. Knock‐out mouse for Canavan disease: a model for gene transfer to the central nervous system , 2000, The journal of gene medicine.
[26] K. Bhakoo,et al. In Vitro Expression of N‐Acetyl Aspartate by Oligodendrocytes , 2000, Journal of neurochemistry.
[27] K. Houkin,et al. Reversible brain dysfunction in MELAS: MEG, and 1H MRS analysis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[28] M W Weiner,et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.
[29] P M Matthews,et al. N‐acetylaspartate: Usefulness as an indicator of viable neuronal tissue , 2001, Annals of neurology.
[30] J Hennig,et al. Absence of N‐acetylaspartate in the human brain: Impact on neurospectroscopy? , 2001, Annals of neurology.
[31] R. Ledeen,et al. Intraneuronal N‐acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin‐associated aspartoacylase , 2001, Journal of neurochemistry.
[32] R. Ledeen,et al. Fatty acid synthesizing enzymes intrinsic to myelin. , 2003, Brain research. Molecular brain research.
[33] C. N. Madhavarao,et al. Characterization of the N‐acetylaspartate biosynthetic enzyme from rat brain , 2003, Journal of neurochemistry.
[34] T. Serikawa,et al. Identification and distribution of aspartoacylase in the postnatal rat brain , 2003, Neuroreport.
[35] R. Matalon,et al. Molecular Basis of Canavan's Disease , 2003, Journal of child neurology.
[36] R. Wevers,et al. Follow-up of a child with hypoacetylaspartia. , 2004, Neuropediatrics.
[37] M. Adachi,et al. Electron miscroscopic and enzyme histochemical studies of the cerebellum in spongy degeneration , 2004, Acta Neuropathologica.
[38] D. Jacobowitz,et al. Immunohistochemical localization of aspartoacylase in the rat central nervous system , 2004, The Journal of comparative neurology.
[39] J. Moffett,et al. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Attwell,et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.
[41] A Freese,et al. Natural History of Canavan Disease Revealed by Proton Magnetic Resonance Spectroscopy (1H‐MRS) and Diffusion-weighted MRI , 2006, Neuropediatrics.
[42] J. Moffett,et al. Expression of N-acetylaspartate and N-acetylaspartylglutamate in the nervous system. , 2006, Advances in experimental medicine and biology.
[43] D. Jacobowitz,et al. Defective myelin lipid synthesis as a pathogenic mechanism of Canavan disease. , 2006, Advances in experimental medicine and biology.
[44] A. De Simoni,et al. Preparation of organotypic hippocampal slice cultures: interface method , 2006 .
[45] R. Ledeen,et al. Axon-myelin transfer of phospholipids and phospholipid precursors , 1992, Molecular Neurobiology.
[46] Morris H. Baslow,et al. Brain N-acetylaspartate as a molecular water pump and its role in the etiology of canavan disease , 2007, Journal of Molecular Neuroscience.
[47] J. Greenfield,et al. Schilder's Encephalitis (Encephalitis Periaxialis Diffusa) , 1926 .
[48] R. Matalon,et al. Bimodal occurrence of aspartoacylase in myelin and cytosol of brain , 2007, Journal of neurochemistry.
[49] T. Serikawa,et al. Myelin Lipid Abnormalities in the Aspartoacylase-Deficient Tremor Rat , 2008, Neurochemical Research.
[50] B. Barres,et al. Nur7 Is a Nonsense Mutation in the Mouse Aspartoacylase Gene That Causes Spongy Degeneration of the CNS , 2008, The Journal of Neuroscience.
[51] R. Reynolds,et al. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. , 2007, Brain : a journal of neurology.
[52] J. Storm-Mathisen,et al. Immunogold quantification of amino acids and proteins in complex subcellular compartments , 2008, Nature Protocols.
[53] P. Courtoy,et al. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. , 2009, The Biochemical journal.
[54] J. Moffett,et al. Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells , 2009, Neurochemistry International.
[55] T. Ben-Hur,et al. Transplanted Neural Precursors Enhance Host Brain-Derived Myelin Regeneration , 2009, The Journal of Neuroscience.
[56] D. Attwell,et al. The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes , 2009, Brain : a journal of neurology.
[57] N. Pattabiraman,et al. Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: Implications for specialized acetyl coenzyme A metabolism in the CNS , 2010, Brain Research.
[58] Howard Y. Chang,et al. G1 arrest and differentiation can occur independently of Rb family function , 2010, The Journal of cell biology.
[59] K. P. Lehre,et al. The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction , 2010, Glia.
[60] D. Bok,et al. Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination , 2010, Neurobiology of Disease.
[61] A. Sartorius,et al. Aspartoacylase-LacZ Knockin Mice: An Engineered Model of Canavan Disease , 2011, PloS one.
[62] D. Jacobowitz,et al. Extensive aspartoacylase expression in the rat central nervous system , 2011, Glia.
[63] D. Attwell,et al. Regulation of Oligodendrocyte Development and Myelination by Glucose and Lactate , 2011, The Journal of Neuroscience.
[64] J. E. Rinholm,et al. Neuroscience: The wrap that feeds neurons , 2012, Nature.
[65] Pierre J. Magistretti,et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration , 2012, Nature.
[66] M. Bates,et al. The Actin-Severing Protein Cofilin Is Downstream of Neuregulin Signaling and Is Essential For Schwann Cell Myelination , 2012, The Journal of Neuroscience.
[67] V. Gundersen,et al. A distinct set of synaptic‐like microvesicles in atroglial cells contain VGLUT3 , 2012, Glia.
[68] V. Gundersen,et al. VGLUT1 is localized in astrocytic processes in several brain regions , 2012, Glia.
[69] N-Acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells. , 2013, The Journal of Biological Chemistry.
[70] P. M. Long,et al. N-Acetylaspartate (NAA) and N-Acetylaspartylglutamate (NAAG) Promote Growth and Inhibit Differentiation of Glioma Stem-like Cells* , 2013, The Journal of Biological Chemistry.